Want to create an interactive transcript for this episode?
Podcast: Surfing the MASH Tsunami
Episode: S3-E10 - Screening and Treatment Pathways in a World with High NAFLD Prevalence
Description: This episode looks at four different sources of data estimating NASH and NAFLD prevalence in population subgroups the US, UK and Germany. All four suggest that the share of people living with NAFLD might be as high as three in eight. This is far too high a screening burden for the hepatology community to manage on its own. However, it should have broader implications for overall treatment pathways.If the liver is the "canary in the (metabolic) coal mine," as Stephen Harrison frequently argues, then everyone in the metabolic disease cascade should be interested in screening patients...